Report Overview
The Global Weight Management Supplements Market Size is expected to be worth around US$ 127.9 Billion by 2034, from US$ 35.8 Billion in 2024, growing at a CAGR of 13.6% during the forecast period from 2025 to 2034.
The Global Weight Management Supplements Market is experiencing robust growth, driven by increasing obesity rates, rising health and wellness consciousness, and advancements in supplement formulation and marketing techniques. Consumers are seeking effective, natural, and convenient solutions to support their weight loss and overall health goals.
The market is highly competitive, with key players such as Herbalife Nutrition Ltd., Glanbia PLC, Abbott Laboratories, Amway, GNC Holdings, and Nestlé Health Science continuously innovating to meet evolving consumer demands.
Regional dynamics vary, with North America and Europe leading the market, while the Asia Pacific region is poised for significant growth due to increasing disposable incomes and health awareness. Despite regulatory challenges, the market presents ample opportunities for growth, particularly in plant-based and personalized nutrition products.
Weight Management Supplements Market, Global Analysis, 2020-2024 (US$ Billion)
| Region | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| North America | 7.0 | 9.5 | 10.2 | 11.2 | 12.4 |
| Europe | 5.6 | 7.7 | 8.3 | 9.1 | 10.1 |
| Asia Pacific | 3.8 | 5.3 | 5.9 | 6.7 | 7.6 |
Key Regions and Countries
- North America
- US
- Canada
- Europe
- Germany
- France
- The UK
- Spain
- Italy
- Russia
- Netherland
- Rest of Europe
- Asia Pacific
- China
- Japan
- South Korea
- India
- New Zealand
- Singapore
- Thailand
- Vietnam
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Rest of MEA
Key Players Analysis
The global weight management supplements market is highly competitive, characterized by the presence of numerous international and regional players. The market’s growth is propelled by rising consumer awareness regarding health and wellness, an increase in obesity rates, and a growing preference for natural and organic products.
Key players in the industry are continuously striving to gain a competitive edge through various strategic initiatives such as mergers and acquisitions, product launches, partnerships, and expansions. Major companies dominating the market include Herbalife Nutrition Ltd., Glanbia PLC, Abbott Laboratories, Amway, GNC Holdings, and Nestlé Health Science.
These companies leverage extensive research and development activities to innovate and introduce new products to meet evolving consumer demands. The market also witnesses significant contributions from smaller players and start-ups that focus on niche segments and offer unique, high-quality products.
Glanbia Plc is a global performance nutrition and ingredients company headquartered in Ireland, specializing in the development, manufacturing, and distribution of nutritional supplements, dairy-based products, and functional ingredients.
In addition, Herbalife Nutrition Ltd., global leader in weight management, nutritional supplements, and personal care products. Headquartered in Los Angeles, the company sells its products through a vast network of independent distributors. Herbalife’s product range includes protein shakes, supplements, and energy drinks designed to support weight management, fitness, and overall well-being.
Top Key Players in the Weight Management Supplements Market
- Glanbia Plc
- Herbalife Nutrition Ltd
- Abbott
- GSK plc.
- NESTLÉ
- Amway Corp.
- NOW Foods
- NutriSports Pharmaceuticals
- BioThrive Sciences
- SMPNutra
Recent Developments
- In April 2024: Glanbia plc, announced that it has entered into an agreement with the shareholders of Aroma Holding Company, LLC and related entities to acquire Flavor Producers LLC. The initial consideration for this acquisition is $300 billion, with additional deferred consideration to be paid as part of the transaction.
- In April 2022: Supernus Pharmaceuticals, Inc. received FDA approval for Qelbree, developed by Supernus Pharmaceuticals, Inc., for treating ADHD patients aged 18 years and above. This approval was anticipated to increase the consumer base for the product.